當前位置:首頁>學者列表>醫學院(FMD) >鄭彥銘>相關期刊列表[ BLOOD(28) ]
排序方式:
    總頁 2 
      Go

    1.Eltrombopag Plus Pulsed Dexamethasone As First Line Therapy for Subjects with Immune Thrombocytopenic Purpura (ITP)

    Zhang, LQ, Zhang, MJ     More...

    BLOOD[0006-4971], Published 2018, Volume 132,

    收錄情况: WOS

    WOS核心合集引用:  2022影響因子:  20.3  发表年影響因子:  16.601 

    2.Vemurafenib As First Treatment of Hairy Cell Leukemia

    Cheng, G, Cheng, G,     More...

    BLOOD[0006-4971], Published 2014, Volume 124, Issue 21,

    收錄情况: WOS

    2022影響因子:  20.3  发表年影響因子:  10.452 

    3.Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study

    Saleh, MN, Bussel, J     More...

    BLOOD[0006-4971], Published 2013, Volume 121, Issue 3, Pages 537-545

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 220  2022影響因子:  20.3  发表年影響因子:  9.775 

    4.Long-Term Safety and Efficacy of Eltrombopag in Adults with Chronic Immune Thrombocytopenia (ITP): Report of up to 5.5 Years of Treatment in EXTEND

    Saleh, MN, Cheng, G,     More...

    BLOOD[0006-4971], Published 2012, Volume 120, Issue 21,

    收錄情况: WOS

    WOS核心合集引用:  2022影響因子:  20.3  发表年影響因子:  9.060 

    5.Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patients

    Powell, JS, Josephso     More...

    BLOOD[0006-4971], Published 2012, Volume 119, Issue 13, Pages 3031-3037

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 189  2022影響因子:  20.3  发表年影響因子:  9.060 

    6.Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patients

    Shapiro, AD, Ragni,     More...

    BLOOD[0006-4971], Published 2012, Volume 119, Issue 3, Pages 666-672

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 137  2022影響因子:  20.3  发表年影響因子:  9.060 

    7.Incidence of Thromboembolic Events Across Eltrombopag Clinical Trials In Chronic Immune Thrombocytopenia (ITP)

    Bussel, JB, Cheng, G     More...

    BLOOD[0006-4971], Published 2010, Volume 116, Issue 21, Pages 37-38

    收錄情况: WOS

    WOS核心合集引用:  2022影響因子:  20.3  发表年影響因子:  10.558 

    8.EXTEND Study Update: Safety and Efficacy of Eltrombopag In Adults with Chronic Immune Thrombocytopenia (ITP) From June 2006 to February 2010

    Saleh, MN, Cheng, G,     More...

    BLOOD[0006-4971], Published 2010, Volume 116, Issue 21, Pages 36-36

    收錄情况: WOS

    WOS核心合集引用:  2022影響因子:  20.3  发表年影響因子:  10.558 

    9.Time to Splenectomy Failure in Patients with Recurrent or Refractory Chronic Immune Thrombocytopenic Purpura

    Cheng, G, Gernsheime     More...

    BLOOD[0006-4971], Published 2009, Volume 114, Issue 22, Pages 1367-1367

    收錄情况: WOS

    2022影響因子:  20.3  发表年影響因子:  10.555 

    10.Thromboembolic Events Observed in Eltrombopag Clinical Trials in Chronic Immune Thrombocytopenic Purpura.

    Bussel, JB, Cheng, G     More...

    BLOOD[0006-4971], Published 2009, Volume 114, Issue 22, Pages 956-957

    收錄情况: WOS

    WOS核心合集引用:  2022影響因子:  20.3  发表年影響因子:  10.555 

    11.Long-Term Treatment of Chronic Immune Thrombocytopenic Purpura with Oral Eltrombopag: Results From the EXTEND Study

    Saleh, MN, Bussel, J     More...

    BLOOD[0006-4971], Published 2009, Volume 114, Issue 22, Pages 285-286

    收錄情况: WOS

    WOS核心合集引用:  2022影響因子:  20.3  发表年影響因子:  10.555 

    12.Evaluation of Hepatobiliary Parameters During Eltrombopag Treatment in Patients with Chronic Immune Thrombocytopenic Purpura

    Maddrey, WC, Cheng,     More...

    BLOOD[0006-4971], Published 2009, Volume 114, Issue 22, Pages 951-952

    收錄情况: WOS

    2022影響因子:  20.3  发表年影響因子:  10.555 

    13.Platelet Counts Following Eltrombopag Discontinuation in Patients with Chronic Immune Thrombocytopenic Purpura

    Cheng, G, Tarantino,     More...

    BLOOD[0006-4971], Published 2009, Volume 114, Issue 22, Pages 1365-1365

    收錄情况: WOS

    2022影響因子:  20.3  发表年影響因子:  10.555 

    14.Safety and Efficacy of Long-Term Treatment with Oral Eltrombopag for Chronic Idiopathic Thrombocytopenic Purpura

    Bussel, JB, Cheng, G     More...

    BLOOD[0006-4971], Published 2008, Volume 112, Issue 11, Pages 1177-1177

    收錄情况: WOS

    WOS核心合集引用:  2022影響因子:  20.3  发表年影響因子:  10.432 

    15.Eltrombopag Delivers Clinical Benefit in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients Not Achieving Platelet Counts >= 50,000/mu L - Data from the EXTEND Study

    Cheng, G, Bussel, JB     More...

    BLOOD[0006-4971], Published 2008, Volume 112, Issue 11, Pages 1176-1176

    收錄情况: WOS

    2022影響因子:  20.3  发表年影響因子:  10.432 

    16.Oral Eltrombopag Treatment Reduces the Need for Concomitant Medications in Patients with Chronic Idiopathic Thrombocytopenic Purpura

    Fogarty, PF, Bussel,     More...

    BLOOD[0006-4971], Published 2008, Volume 112, Issue 11, Pages 1174-1174

    收錄情况: WOS

    WOS核心合集引用:  2022影響因子:  20.3  发表年影響因子:  10.432 

    17.Oral Eltrombopag for the Long-Term Treatment of Patients with Chronic Idiopathic Thrombocytopenic Purpura: Results of a Phase III,. Double-Blind, Placebo-Controlled Study (RAISE)

    Cheng, G, Saleh, MN,     More...

    BLOOD[0006-4971], Published 2008, Volume 112, Issue 11, Pages 153-154

    收錄情况: WOS

    WOS核心合集引用:  2022影響因子:  20.3  发表年影響因子:  10.432 

    18.Eltrombopag Is Efficacious in Patients with Refractory Chronic Idiopathic Thrombocytopenic Purpura (ITP) - Data from the EXTEND Study

    Saleh, MN, Bussel, J     More...

    BLOOD[0006-4971], Published 2008, Volume 112, Issue 11, Pages 154-154

    收錄情况: WOS

    2022影響因子:  20.3  发表年影響因子:  10.432 

    19.Long-term safety and efficacy of oral eltrombopag for-the treatment of subjects with idiopathic thrombocytopenic purpura (ITP): Preliminary data from the EXTEND study

    Brussels, JB, Cheng,     More...

    BLOOD[0006-4971], Published 2007, Volume 110, Issue 11, Pages 174A-174A

    收錄情况: WOS

    2022影響因子:  20.3  发表年影響因子:  10.896 

    20.Platelet counts remain elevated in two patients with idiopathic thrombocytopenic purpura after cessation of oral eltrombopag

    Cheng, G

    BLOOD[0006-4971], Published 2007, Volume 110, Issue 11, Pages 49B-49B

    收錄情况: WOS

    WOS核心合集引用:  2022影響因子:  20.3  发表年影響因子:  10.896 

    顯示      條  合計   28   條
      總頁 2 
        Go

      本系統需要使用 Internet Explorer 9.0 以上Firefox || Chrome瀏覽器

      Copyright © 2018 澳門科技大學學者庫